Skip to main content

Table 3 Effect of treatment with partially purified antifungal secondary metabolite (PPASM) and purified ASM (PASM) on β-1,3-glucan level in the cell wall of Aspergillus parasiticus

From: A novel strain of Bacillus amyloliquefaciens displaying broad spectrum antifungal activity and its underlying mechanism

Treatment of A. parasiticus

Glucose concentration (μg/mg mycelium)

Control (untreated)

102 ± 2.6 a

PPASM

23 ± 1.9 b

PASM

1 ± 0.1 c

  1. Data are presented as the mean ± standard deviation (SD) of 3 different sets of experiments performed in triplicate. Values followed by different lowercase letters are significantly different at the 0.05 level of significance (P < 0.05) as analyzed by one-way analysis of variance (ANOVA)